Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours

Clinical trial NCT03101839 · COMPLETED

Trial details

NCT number: NCT03101839
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Advanced Solid Tumours

Start date: 2017-05-15
Primary completion: 2019-01-08
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.